Skip to content

Effects of intravenous injection of different doses of lidocaine on intracranial pressure during supine position spinal surgery

Effects of intravenous injection of different doses of lidocaine on intracranial pressure during supine position spinal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118033
Enrollment
Unknown
Registered
2026-02-01
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative intracranial pressure

Interventions

Lidocaine high-dose group (L2 group):Lidocaine at a dose of 2mg/(kg·h) is intravenously pumped
Control group (group C):Equal volume sodium chloride injection is intravenously pumped
Lidocaine low-dose group (L1 group):Lidocaine at a dose of 1mg/(kg·h) is intravenously pumped

Sponsors

Ningxia Hui Autonomous Region People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Elective prone position spinal endoscopic surgery under general anesthesia was performed. The surgical types included endoscopic lumbar discectomy, endoscopic posterior approach lumbar interbody fusion, discectomy spinal canal decompression, lumbar laminectomy decompression, etc.; 2. Age >=18 and <=75 years old; 3. The body mass index (BMI) is 18-28 kg/m^2; 4. The ASA classification of the American Society of Anesthesiologists is grade I-II; 5. Have normal cognitive and communication skills.

Exclusion criteria

Exclusion criteria: 1. Has a history of drug allergy to lidocaine; 2. History of concurrent ocular diseases, such as ocular trauma, optic neuritis, optic nerve tumors, retinopathy, glaucoma, cataracts, etc.; 3. Combined with central nervous system diseases and cerebrovascular diseases, such as motion sickness, intracranial infection, cerebrovascular accident, intracranial tumor, etc.; 4. Previous history of eye surgery and ocular trauma; History of craniocerebral trauma and craniocerebral surgery; 5. Combined with severe respiratory, circulatory or endocrine system diseases; 6. Patients with severe liver and kidney dysfunction and coagulation disorders; 7. Limited cervical spine movement or ultrasound suggesting carotid artery plaque formation; 8. Recently taken medications that affect cerebrospinal fluid pressure, such as diuretics and glucocorticoids, etc.

Design outcomes

Primary

MeasureTime frame
Optic nerve sheath diameter;

Secondary

MeasureTime frame
Intraoperative vital signs;Recovery time for spontaneous breathing;Awakening time;Extubation time;Extubation time;Riker rating;Postoperative VAS pain score;Three day postoperative complications;Occurrence and extent of adverse reactions related to lidocaine (perioral numbness, bradycardia, hypotension);Use of emergency antiemetic drugs;Use of emergency analgesics;

Countries

China

Contacts

Public ContactYe Zhenhai, Song Yuying

Ningxia Hui Autonomous Region People's Hospital

13619506202@163.com+86 136 1950 6202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026